First Description and Search for
as 'a bacillary infectious disease, which is either Aetiology identical with tuberculosis or closely related to it', however, proof of this hypothesis remains A number of the characteristics of the disease elusive. Nevertheless, there is an ongoing discusknown today as sarcoidosis were first described sion of this question. Using methods of histology in the 18th and 19th centuries. In 1798 erythema and molecular biology the presence of acid fast nodosum was described by William, and as early rods, mycobacterial DNA and mycobacterial rRNA as in 1882 the microscopical characteristics of has been demonstrated in sarcoidosis. [4] [5] [6] epitheloid and giant cells were reported by Ten-However, other 14 and Boeck's multiple sarcoids are manifestations Epidemiological data and similarities with of the same disease, that this disease might also other infectious diseases support the hypothesis involve the lymph nodes, the mucosa of the that sarcoidosis is induced by an infectious agent. nose, the tonsils, the bones and the lungs, and Seasonal clustering of sarcoidosis in the months that all of these manifestations are characterized of June and July, .5 time. and space clusters, 16 '17 by a histological pattern which he summarized as an increased incidence in health workers, 18 and a 'tuberculoid granulomatous process'. Schau-the transmission of sarcoidosis by transplants 9 mann suggested the term 'lymphogranulomatosis have been observed and further support the benigna' for the disease since it appears to hypothesis of transmissible agents inducing sarinvolve predominantly the lymphatic system. In coidosis. Most interestingly, there are numerous this essay published in 1934 he identified radio-reports of sarcoidosis patients who suffered from graphic changes of the bone due to sarcoidosis a relapse of sarcoidosis in a transplanted lun2 and typical histological changes in different despite receiving immunosuppressive therapy. organs, thus demonstrating that an affection of Vice versa a patient receiving a lung from a the skin is not mandatory for the diagnosis of donor who had a spontaneous remission of sarsarcoidosis. 2' coidosis in the past was observed to develop As early as 1905 Boeck described sarcoidosis sarcoid-like lesions. These observations suggest that the aetiological agent hides within the lung loosely arranged cells like a collar of lymphoand/or in other compartments of the body. cytes, monocytes, and fibroblasts ( Fig. 1) . 22, 25 Despite the efforts made to The most tissues of non-caseating epitheloid-cell granulotelling contribution that could be made to our mas, proceeding either to resolution or to conknowledge of this peculiar condition would be version into hyaline connective tissue'. 22 The the discovery of its aetiology. ' 99 This leads to significant differences were observed. In Group the hypothesis that this cytokine might be III (persistent disease)3/3 patients had undetectinvolved in the down-regulation of sarcoid able IL-2 levels. In Group IV (receiving corticoinflammation which was tested in a clinical study, steroids), however, 1/3 patients showed an eleFor this purpose sarcoid patients were categor-vated IL-2 release (Fig. 4) . ized into four groups: Group I consisted of Although" pro-inflammatory cytokines. 87 14 As Lysozym and angiotensin converting enzyme are expected, elevated serum levels were found in products of epitheloid cells creating elevated sarcoidosis and are used to monitor the activity serum levels in sarcoidosis. These serum levels of cells of the macrophage/monocyte lineage in 40 142 143 reflect the granuloma burden of the entire body the course of the disease.
Interestingly, a and can be used for a clinical assessment of the correlation between BAL cell TNFa or IL-6 granulomatous inflammation. 126'127 These serum release with serum neopterin could not be parameters are frequently used in everyday prac-observed 6 eases. 29'3 It has to be kept in mind that none of the CD14 is the most specific marker for cells of above-mentioned parameters can be used to the monocyte/macrophage lineage -and its establish a diagnosis. Elevated levels are found in expression is age, race and gender indepena number of diseases. Once the diagnosis of sardent. 4 Reports concerning expression of CD14 coidosis has been made, the inflammatory activity on alveolar macrophages in healthy volunteers .of the immunopathogenetical processes deand 154 Owing to the fact that the genes of IL-2 and IL-2R are coexpressed the enumeration of IL-2R positive T-cells was considered to be an approach to estimate the number of activated alveolar T-cells. Only a moderate increase in IL-2R + T-cells was observed, 148'55'156 suggesting the presence of a small number of activated cells in the alveolar space or a dysregulation in the expression of the IL-2R. Results obtained by an in vitro study with sarcoid T-cells excluded the latter possibility. 48 Other immunological disorders, e.g. rheumatoid arthritis and multi_pie sclerosis, also exhibit small increases in IL-2R--T-cells at the site of inflammation, i.e. the synovial surface and the multiple sclerosis lesions, respectively, thus supporting the 157 158 above-mentioned finding. However, the milieu of the lower respiratory tract generated by pulmonary epithelial cells type II modulates the reactivity of the T-cells. In the presence of type II epithelial cells activated T-cells become arrested and do not progress in the cell cycle. When leaving this milieu the blockade is reversed, e.g. after 159 160 migration of the T-cells to the lymph nodes. The described scenario may also apply for sarcoidosis where a lymphocyte proliferation can be observed in sarcoid lymph nodes.
The majority of the findings with regard to sarcoid T-cell response are characteristic of a Tcell mediated response to antigen and are highly suggestive of the presence of a persistent, poorly degradable antigen or antigens. In 1988 a bias towards an increased usage of the V8 region of the T-cell-antigen receptor in sarcoidosis peripheral blood and bronchoalveolar lavage T-lymphocytes was demonstrated, suggesting that T-cells accumulate secondary to external selective pressure, rather than in a random polyclonal fashion or by clonal expansion of one or a few T-cell clones. 2 This observation has been extended showing restricted usage of T-cell antigen receptor V, -l V, 4 and Cfl-chains 165 in bronchoalveolar lavage and lung parenchyma. However, other technical approaches have demonstrated an increased clonality in bronchoalveolar lavage cells without detecting preferred V-region families, leading to the assumption that the major source of T-cells is a polyclonal unspecific accumulation accompanied by a clonal expansion being different in every patient and contributing about 10% of the T-cells. -9 In normals an oligoclonality in the V-region usage of lung T-cell clones compared with blood clones could not be found.
In summary the sarcoidosis studies revealed a number V-and Vfl-family selections of the T-cell-antigen receptor in the detected clones, thus supporting the hypothesis of an unspecific stimulus. It can be concluded that the elusive agent or agents eliciting sarcoidosis select T-cell clones in the lung and other involved organs accompanied by an unspecific polyclonal T-cell accumulation as described for normal immune reactions. 71 This concept of compartmentalization is further supported by studies of autoimmune and chronic inflammatory diseases demonstrating a compartmentalized accumulation of T-cells with some restrictions in V-chain gene usage.
172-174
The cytokine release by pulmonary lymphocytes is 37'223 Thus, organ-specific immunoregulatory mechanisms render the lung into a specialized immunological environment with a low responsiveness at the site of first antigen contact. 9'159 In spite of the fact that effective immune stimulation takes place in the lower respiratory tract only few of the activated cells undergo mitosis 5, 5 but leave the lung 16'224 and proliferate in the regional lymph nodes. 6, 225 Studies of the pulmonary immune response in health and disease gave further support for this concept of compartmentalization. The immunoglobulin production of B-lymphocytes of the lung continues over a relatively long time after the lung is transplanted and seems to function independent of the immune system of the graft. 226 Immunophenotyping of the T-cells on the alveolar epithelial surface of healthy individuals revealed that these cells are permanently activated and exchange only very slowly with the blood pool 5'227 explaining the delayed changes of the diseased immunophenotypes when the 228 patients are under therapy. Local instillation of bacteria into the lung leads to neutrophil and cytokine accumulation in the area of instillation.
If, however, the instillation dose is higher cells and mediators accumulate in the noninstilled parts of the lung as well and a systemic cytokine release is observed 229 indicating that the reactions to overwhelming injury cannot be confined to the lung as it can be seen from the systemic reaction, e.g. fever and myalgia, in sarcoidosis and other lung diseases.
